Media Watch - NVX related, page-6560

2 years hold. Had $150M capital so should not need a capital rising anytime soon.

Rapid Battery Development Solutions

• Spun out of Dr. Jeff Dahn’s laboratory at Dalhousie University, NOVONIX manufactures high-precision coulometry (HPC) cyclers.
• NOVONIX provides the most accurate and precise battery testing services and equipment in the world, delivering results rapidly in a matter of weeks.

This is there competitive advantage.

Traditional methods of testing the lifetime of a lithium-ion battery can take months or even years. But Novonix has narrowed down the testing period to weeks.

"We developed and commercialized a system that is more accurate than what anyone else is building in the market and that allowed researchers to gain insight into the performance of their batteries in only a few weeks what through traditional methods might take months or years," Burns says.

According to Bloomberg consensus data, Novonix is forecast to grow revenue by 69% year on year to $8.8 million in FY22, with that expanding more than 478% to $51 million in FY23 and $141 million in FY24.

However, it’s also forecast to produce a net loss into FY23, before turning profitable in FY24, according to this data.

Noteworthy is that FY22’s projected loss of $35 million is more than its FY21 result of a $16 million loss.

It’s not uncommon for ‘growth‘ companies to present with negative earnings and high revenue growth forecasts. However, the high-growth trade has arguably unwound itself this year.